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Genomics in health and disease
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Shams University
Genomics is the study of all person’s genes including interactions of those 
genes with each other and person’s environment. Many Factors contribute to 
human health and disease. Our environment and our biology are two factors 
that strongly influence our health. For along time, it was believed that disease 
resulted entirely from our environment or entirely from our biology. Now we are 
seeing that many human diseases are a result of a complex interaction between 
our biology and our environment and many other factors. The completion of the 
Human Genome Project signaled that the genome revolution was here to stay 
and symbolized its promise that knowing the DNA sequence of our genome 
and those of hundreds of other organisms would allow us to take on the greatest 
challenges of human health and alleviate human suffering. The Aim of this 
review is to discuss the influence of genomics on global health and genetics 





Genomics, genetics, gene regulation, 
mutation, genetic testing.
What is Genetics and Genomics?
Genetics is a term that refers to the 
study of genes and their role in inheri-
tance. Gene influence traits such as hair 
and eye color as well as health and dis-
ease development. Genetics determines 
much (but not all) of a person’s appear-
ance and health status, but environmen-
tal differences also play a part. Examples 
of single gene disorders that would be 
considered as “Genetics” include cystic 
fibrosis and PKU (Phenyl ketonuria).1 
Genomics is a relatively new term that 
describes the study of all of a person’s 
genes including interactions of those 
genes with each other and person’s en-
vironment. Genomics involves the sci-
entific study of complex diseases such 
as heart disease, asthma, diabetes and 
cancer because they are caused more 
by a combination of genetic and envi-
ronmental factors.2 Understanding the 
relationships among these factors at the 
population level may provides new op-
portunities for prevention and interven-
tion.3
Why is genetics and genomics impor-
tant to our health?
Genetics and genomics both play a role 
in health and disease. Genetics helps in-
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dividuals and families learn about how 
conditions, such as sickle cell anemia, 
are inherited in families; what screen-
ing and testing is available and in for 
some genetic conditions treatment.4
Genomics is helping to discover why 
some people get sick from certain in-
fections, environmental factors and be-
haviors, while others do not. Genomics 
holds the key to these differences.5 All 
human beings are 99.9% percent identi-
cal in their genetic makeup. Differences 
in the remaining 0.1% hold important 
clues about the causes of diseases. Hav-
ing a better understanding of the inter-
actions between genes and the environ-
ment is helping us find better ways to 
improve health and prevent disease.6
Why is genetics and genomics impor-
tant to our family’s health?
Understanding more about single gene 
disorders (Genetics) and complex dis-
eases (Genomics) can lead to ealier di-
agnosis, interventions and targeted treat-
ments. A person’s health is influenced 
by his/her family history and shared 
environmental factors. Family history 
is an important personalized tool that 
captures many of the gene/environment 
interactions, for conditions that are ge-
netic and genomic in origin.7 The fam-
ily history can serve as the cornerstone 
for learning about genetic and genomic 
conditions in family and individual dis-
ease prevention.8
Impact of gene regulation on health 
and disease
Looking at single inherited variations 
in the human genome, the research-
ers try to gain new insights into gene 
regulation and their impact on health 
and disease. They are especially inter-
ested in the development of regulation 
throughout millions of years of human 
evolution. To do this, they combined 
two methods in genome research-the 
research for single nucleotide polymor-
phisms (SNPS), which can influence 
the correct expression of genes, with 
population genetics. This strategy en-
ables the researchers not only to look at 
gene regulation, but also to detect those 
variations in the genome which can 
cause human disease9. Gene regulation 
is a basic process which regulates hu-
man development and is important for 
health and disease. Genes are sections 
of the hereditary molecule DNA which 
contain the blue print for proteins, the 
building blocks and molecular ma-
chineries of life10. The DNA molecule 
is made up of 3,2 billion nucleotides. 
However, each human individual has a 
different sequence of nucleotides. One 
individual, for example, can have an 
Adenin (A) nucleotide, whereas, at the 
same position, another individual has 
cytosine (C) nucleotide11. Researchers 
estimate that, the human genome has 
eleven million of such single nucleotide 
variants polymorphisms (SNPs). Their 
aim is to detect these SNPs and find out 
their function in health and disease. The 
key to human variation is mutation12. 
A mutation is simply a change in the 
genetic information. Our genome con-
sists of more than billion nucleotides 
that can acquire a mutation at any time 
throughout our lives. Every humanbe-
ing carries several mutations in their ge-
nome. Most of these mutations are “Si-
lent” and harmless and never have an 
effect on our health. Others may make 
us more susceptible to some diseases 
and whether or not we develop those 
diseases depends on many other fac-
tors, including the rest of our genes and 
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our environment. Still others can pre-
dispose us to disease that may develop 
later in life, which is also influenced by 
other factors. Finally, some mutations 
result directly in disease if they inter-
rupt an essential function in our body.13
Genomics and disease:
Many factors contribute to human 
health and disease. Our environment 
and biology are two factors that strong-
ly influence our health. For a long time, 
it was believed that disease resulted en-
tirely from our environment such as tu-
berculosis or entirely from our biology, 
such as an inherited disease like cystic 
fibrosis. Now, we are seeing that many 
human diseases are a result of complex 
interaction between our biology and en-
vironment and many other factors.14
So Genomics is a powerful tool for un-
derstanding the totality of the factors 
that contribute to health and disease, 
i.e. genetic and environmental interac-
tions.15
Translating genomics into usable in-
formation:
Three major efforts are underway to 
translate genomics into usable in-
formation for improving population 
health:16
1. Integrating genomics into pub-
lic health Investigations (PHIS). 
(Therefore we can define public 
health genomics as the inclusion 
and applicaton of genomic infor-
mation and tools in public health 
planning, policy and programs).
2. Analyzing genetic variation among 
specimens in the National health 
and Nutrition Examination Survey 
(NHANES) lllDNA Bank.
3. Expanding the Human Genome 
Epidemiology Network (HUGE 
NetTM).
Thus genomics should be considered in 
every fact of public health: infectious 
disease, chronic disease, occupational 
health, environmental health, in addi-
tion to maternal and child health.17
Genetics, genomics and patient man-
agement:
The influence of genomics on global 
health certainly extends well beyond 
our ability to better diagnose, prevent 
and treat human disease. The 2002 
World Health Organization report on 
Genomics and Global Health, while 
affirming the importance of genomics, 
also warned of a “Genomic divide”- 
poor countries may be unable to share 
the benefits of genomic research-thus 
further exacerbating the inequities in 
global health.18 New genetic and ge-
nomic research discoveries are ushering 
in a new era of health care-personalized 
medicine. Personalized medicine has 
the potential to transform health care by 
associating genotypes with phenotypes, 
through improved diagnostic methods, 
early detection of predisposing genetic 
variation (Disease susceptibility), more 
effective prevention and treatment of 
disease and avoidance of drug side ef-
fect.19
Genetic testing:
The term “Genetic testing” cover an ar-
ray of techniques including analysis of 
human DNA, RNA or protein. Genetic 
tests are used as a health care tool to 
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detect gene variants associated with a 
specific disease or condition, as well as 
for non-clinical uses such as paternity 
testing and forensics. In the clinical set-
ting, genetic tests can be performed to 
confirm a suspected diagnosis, to pre-
dict the possibility of future illness, to 
detect the presence of a carrier state in 
unaffected individuals and to predict 
response to therapy. They are also per-
formed to screen fetuses; newborns or 
embryos used in-vitro fertilization for 
genetic defects.20
Ethical, Legal and social implica-
tions: (ELSI)
Today’s genomics research and appli-
cations rest on more than a decade of 
valuable investigation into their ethi-
cal, legal and social implications. As 
the application of genomics to health 
increase along with its social impact, it 
becomes more important to expand on 
this work.21
Ethical, Legal and Social Issues in-
clude:
1. Fairness in the use of genetic in-
formation by insurers, employers, 
courts, schools, adoption agencies 
and the military, among others.
2. Privacy and confidentiality of ge-
netic information.
3. Psychological impact and Stigma-
tization due to individual’s genetic 
differences.
4. Reproductive issues including ad-
equate informed consent for com-
plex and potentially controversial 
procedures, use of genetic informa-
tion in reproductive decision mak-
ing and reproductive rights.
5. Clinical issues including the edu-
cation of doctors and other health 
service providers, patients and the 
general public in genetic capabili-
ties, scientific limitations and social 
risks; and implementation of stan-
dards and quality-control measures 
in testing procedures.22
6. Uncertainties associated with gene 
tests for susceptibilities and com-
plex conditions linked to multiple 
genes and gene–environment inter-
actions.
7. Conceptual and philosophical im-
plications regarding human respon-
sibility and concepts of health and 
disease.
8. Health and environmental issues 
concerning genetically modified 
and microbes.
9. Commercialization of Products in-
cluding property rights and acces-
sibility of data and materials.23
Finally we can say that genomics will 
make a world of difference.
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